Review



bone marrow  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    PromoCell bone marrow
    Bone Marrow, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 196 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow/product/PromoCell
    Average 96 stars, based on 196 article reviews
    bone marrow - by Bioz Stars, 2026-02
    96/100 stars

    Images



    Similar Products

    96
    PromoCell bone marrow
    Bone Marrow, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow/product/PromoCell
    Average 96 stars, based on 1 article reviews
    bone marrow - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    PromoCell bone marrow bm hmscs
    Bone Marrow Bm Hmscs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow bm hmscs/product/PromoCell
    Average 96 stars, based on 1 article reviews
    bone marrow bm hmscs - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    PromoCell bone marrow derived mscs
    Bone Marrow Derived Mscs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow derived mscs/product/PromoCell
    Average 96 stars, based on 1 article reviews
    bone marrow derived mscs - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    PromoCell human bone marrow
    Human Bone Marrow, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow/product/PromoCell
    Average 96 stars, based on 1 article reviews
    human bone marrow - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    PromoCell human bone marrow derived mesenchymal stem cells hbm msc
    hiPSC differentiate into cells with an MSC phenotype exhibiting common MSC markers. A schematic of the MSC differentiation protocol is shown (a) (Created with BioRender.com ). Fold gene expression increases in MSC marker-genes THY1 (CD90), NT5E (CD73) and ENG (CD105) was observed throughout differentiation of hiPSC-iMSCs (b). Histograms for common MSC positive markers are displayed (c) and increase of the percentage of cells positive for CD90, CD73 and CD105 after 36 days could also be noticed via flow cytometry (C-i to C-iii) after 36 days when iMSCs were derived. Homogenous iMSC populations comparable to <t>hBM-MSCs</t> positive for phenotypical MSCs markers CD44 and CD73 (green) as well as CD105 and CD90 (red) could be observed by day 34 of differentiation via Immunofluorescence staining (d). Scale bars shown at 100 μm. Data significance is presented as *** p ⩽ 0.001 and **** p ⩽ 0.0001 ( n = 3).
    Human Bone Marrow Derived Mesenchymal Stem Cells Hbm Msc, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow derived mesenchymal stem cells hbm msc/product/PromoCell
    Average 96 stars, based on 1 article reviews
    human bone marrow derived mesenchymal stem cells hbm msc - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    PromoCell human bone marrow mesenchymal stem cells hmscs
    A) Synthesis of COPMA‐XG hydrogels. B) Interpenetrating network (covalent bonds and hydrogen bonds) in COPMA‐XG hydrogels. COPMA were covalently crosslinked under UV exposure. Hydrogen bonds existed between COPMA and XG. C) Self‐healing properties of COPMA‐XG hydrogels. D) <t>hMSCs</t> laden COPMA‐XG constructs were bioprinted and cultured in proliferation and differentiation media over 28 days. This figure was created with BioRender.com and has been granted a publication license.
    Human Bone Marrow Mesenchymal Stem Cells Hmscs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow mesenchymal stem cells hmscs/product/PromoCell
    Average 96 stars, based on 1 article reviews
    human bone marrow mesenchymal stem cells hmscs - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    hiPSC differentiate into cells with an MSC phenotype exhibiting common MSC markers. A schematic of the MSC differentiation protocol is shown (a) (Created with BioRender.com ). Fold gene expression increases in MSC marker-genes THY1 (CD90), NT5E (CD73) and ENG (CD105) was observed throughout differentiation of hiPSC-iMSCs (b). Histograms for common MSC positive markers are displayed (c) and increase of the percentage of cells positive for CD90, CD73 and CD105 after 36 days could also be noticed via flow cytometry (C-i to C-iii) after 36 days when iMSCs were derived. Homogenous iMSC populations comparable to hBM-MSCs positive for phenotypical MSCs markers CD44 and CD73 (green) as well as CD105 and CD90 (red) could be observed by day 34 of differentiation via Immunofluorescence staining (d). Scale bars shown at 100 μm. Data significance is presented as *** p ⩽ 0.001 and **** p ⩽ 0.0001 ( n = 3).

    Journal: Journal of Tissue Engineering

    Article Title: Blood vessels bioengineered from induced pluripotent stem cell derived mesenchymal stem cells and porous silk fibroin coated functional scaffolds

    doi: 10.1177/20417314251355723

    Figure Lengend Snippet: hiPSC differentiate into cells with an MSC phenotype exhibiting common MSC markers. A schematic of the MSC differentiation protocol is shown (a) (Created with BioRender.com ). Fold gene expression increases in MSC marker-genes THY1 (CD90), NT5E (CD73) and ENG (CD105) was observed throughout differentiation of hiPSC-iMSCs (b). Histograms for common MSC positive markers are displayed (c) and increase of the percentage of cells positive for CD90, CD73 and CD105 after 36 days could also be noticed via flow cytometry (C-i to C-iii) after 36 days when iMSCs were derived. Homogenous iMSC populations comparable to hBM-MSCs positive for phenotypical MSCs markers CD44 and CD73 (green) as well as CD105 and CD90 (red) could be observed by day 34 of differentiation via Immunofluorescence staining (d). Scale bars shown at 100 μm. Data significance is presented as *** p ⩽ 0.001 and **** p ⩽ 0.0001 ( n = 3).

    Article Snippet: Human bone marrow derived mesenchymal stem cells (hBM-MSC) (C-12974) harvested from normal human bone marrow from individual donors were cultured with Mesenchymal Stem Cell Growth Medium 2 (C-28009) purchased from PromoCell (Germany).

    Techniques: Gene Expression, Marker, Flow Cytometry, Derivative Assay, Immunofluorescence, Staining

    Characterisation of iMSC and hBM-MSCs via alizarin red staining. Both iMSCs (a-i) and hBM-MSCs (j-l) underwent osteogenic differentiation with noticeable mineralisation nodules being produced by the end of differentiation (day 28) as displayed by alizarin red staining. Images were collected on an Olympus IX83 inverted microscope and captured through MMI CellTools software at 10× magnification. Scale bars shown at 200 μm.

    Journal: Journal of Tissue Engineering

    Article Title: Blood vessels bioengineered from induced pluripotent stem cell derived mesenchymal stem cells and porous silk fibroin coated functional scaffolds

    doi: 10.1177/20417314251355723

    Figure Lengend Snippet: Characterisation of iMSC and hBM-MSCs via alizarin red staining. Both iMSCs (a-i) and hBM-MSCs (j-l) underwent osteogenic differentiation with noticeable mineralisation nodules being produced by the end of differentiation (day 28) as displayed by alizarin red staining. Images were collected on an Olympus IX83 inverted microscope and captured through MMI CellTools software at 10× magnification. Scale bars shown at 200 μm.

    Article Snippet: Human bone marrow derived mesenchymal stem cells (hBM-MSC) (C-12974) harvested from normal human bone marrow from individual donors were cultured with Mesenchymal Stem Cell Growth Medium 2 (C-28009) purchased from PromoCell (Germany).

    Techniques: Staining, Produced, Inverted Microscopy, Software

    Proliferation and metabolic activity of hBM-MSC and iMSCs. A diagram of the modifications made to the pristine (1) scaffolds by immersing in acetone ⩾ 99.8% acetone to produce porous (2) fibres and further covered with a 1% w/v silk fibroin solution to coat scaffolds (3) (a) (Created with BioRender.com ). The modifications to the scaffolds were assessed to evaluate their biocompatibility compared to the control pristine elcetrospun scaffolds. The three different types of scaffolds were visualised under SEM imaging. Pristine scaffolds produced by electrospinning without any post-electrospinning modification (b). Cells count differences in iMSCs and hBM-MSCs seeded on pristine, porous and silk fibroin coated scaffolds after and reduction of AlamarBlue™ differences in iMSCs and hBM-MSCs seeded on pristine, porous and silk fibroin coated scaffolds after 10 days of culture (c) Density and morphological differences between the scaffold conditions were also observed via immunofluorescence staining with Phalloidin-iFluor 488 (a). Scale bars shown at 100 μm (d). Data significance is presented as * p < 0.05, ** p ⩽ 0.01, *** p ⩽ 0.001 ( n = 3).

    Journal: Journal of Tissue Engineering

    Article Title: Blood vessels bioengineered from induced pluripotent stem cell derived mesenchymal stem cells and porous silk fibroin coated functional scaffolds

    doi: 10.1177/20417314251355723

    Figure Lengend Snippet: Proliferation and metabolic activity of hBM-MSC and iMSCs. A diagram of the modifications made to the pristine (1) scaffolds by immersing in acetone ⩾ 99.8% acetone to produce porous (2) fibres and further covered with a 1% w/v silk fibroin solution to coat scaffolds (3) (a) (Created with BioRender.com ). The modifications to the scaffolds were assessed to evaluate their biocompatibility compared to the control pristine elcetrospun scaffolds. The three different types of scaffolds were visualised under SEM imaging. Pristine scaffolds produced by electrospinning without any post-electrospinning modification (b). Cells count differences in iMSCs and hBM-MSCs seeded on pristine, porous and silk fibroin coated scaffolds after and reduction of AlamarBlue™ differences in iMSCs and hBM-MSCs seeded on pristine, porous and silk fibroin coated scaffolds after 10 days of culture (c) Density and morphological differences between the scaffold conditions were also observed via immunofluorescence staining with Phalloidin-iFluor 488 (a). Scale bars shown at 100 μm (d). Data significance is presented as * p < 0.05, ** p ⩽ 0.01, *** p ⩽ 0.001 ( n = 3).

    Article Snippet: Human bone marrow derived mesenchymal stem cells (hBM-MSC) (C-12974) harvested from normal human bone marrow from individual donors were cultured with Mesenchymal Stem Cell Growth Medium 2 (C-28009) purchased from PromoCell (Germany).

    Techniques: Activity Assay, Control, Imaging, Produced, Modification, Immunofluorescence, Staining

    Vessel-like constructs derived from hBM-MSCs and iMSCs. Diagram of the fabrication process of tissue engineered blood vessels (a) (Created with BioRender.com ). The tube construct post-production can be seen next to the steel rod used to fabricate next and next to a penny for scale comparison (bi). Length dimensions (bii), wall thickness and inner diameter dimensions (biii) are also displayed. Immunofluorescence images of longitudinal cross-sections of tube constructs (b). Vessel mimics fabricated using both hBM-MSC-VSMCs and iMSC-VSMCs can be observed to be densely-populated with cells positive for α-SMA (green) and CNN1 (red). DAPI was counterstained to show nuclei. Scale bars shown at 100 μm. The representation of the scale is displayed in (c) Mechanical property differences in UTS (d), burst strength (e), young’s modulus (f) and strain (g) were also measured. Data significance is presented as * p < 0.05 ( n = 3).

    Journal: Journal of Tissue Engineering

    Article Title: Blood vessels bioengineered from induced pluripotent stem cell derived mesenchymal stem cells and porous silk fibroin coated functional scaffolds

    doi: 10.1177/20417314251355723

    Figure Lengend Snippet: Vessel-like constructs derived from hBM-MSCs and iMSCs. Diagram of the fabrication process of tissue engineered blood vessels (a) (Created with BioRender.com ). The tube construct post-production can be seen next to the steel rod used to fabricate next and next to a penny for scale comparison (bi). Length dimensions (bii), wall thickness and inner diameter dimensions (biii) are also displayed. Immunofluorescence images of longitudinal cross-sections of tube constructs (b). Vessel mimics fabricated using both hBM-MSC-VSMCs and iMSC-VSMCs can be observed to be densely-populated with cells positive for α-SMA (green) and CNN1 (red). DAPI was counterstained to show nuclei. Scale bars shown at 100 μm. The representation of the scale is displayed in (c) Mechanical property differences in UTS (d), burst strength (e), young’s modulus (f) and strain (g) were also measured. Data significance is presented as * p < 0.05 ( n = 3).

    Article Snippet: Human bone marrow derived mesenchymal stem cells (hBM-MSC) (C-12974) harvested from normal human bone marrow from individual donors were cultured with Mesenchymal Stem Cell Growth Medium 2 (C-28009) purchased from PromoCell (Germany).

    Techniques: Construct, Derivative Assay, Comparison, Immunofluorescence

    A) Synthesis of COPMA‐XG hydrogels. B) Interpenetrating network (covalent bonds and hydrogen bonds) in COPMA‐XG hydrogels. COPMA were covalently crosslinked under UV exposure. Hydrogen bonds existed between COPMA and XG. C) Self‐healing properties of COPMA‐XG hydrogels. D) hMSCs laden COPMA‐XG constructs were bioprinted and cultured in proliferation and differentiation media over 28 days. This figure was created with BioRender.com and has been granted a publication license.

    Journal: Advanced Healthcare Materials

    Article Title: Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration

    doi: 10.1002/adhm.202502341

    Figure Lengend Snippet: A) Synthesis of COPMA‐XG hydrogels. B) Interpenetrating network (covalent bonds and hydrogen bonds) in COPMA‐XG hydrogels. COPMA were covalently crosslinked under UV exposure. Hydrogen bonds existed between COPMA and XG. C) Self‐healing properties of COPMA‐XG hydrogels. D) hMSCs laden COPMA‐XG constructs were bioprinted and cultured in proliferation and differentiation media over 28 days. This figure was created with BioRender.com and has been granted a publication license.

    Article Snippet: Human bone marrow mesenchymal stem cells (hMSCs) from PromoCell (donor Caucasian woman, 30 years old) were cultured in T225 flasks at a density of 1000 cells cm −2 in proliferation medium.

    Techniques: Construct, Cell Culture

    Biocompatibility of hMSCs laden COPMA 15 ‐XG 3.5 constructs. A) Optical image of bioprinted hMSCs laden COPMA 15 ‐XG 3.5 hydrogel. B) Size statistics of bioprinted constructs. C) Metabolic activity. D‐E) Live/dead staining of hydrogels in proliferation medium, and in differentiation medium, scale bar: 500 µm. F) SEM of hMSC encapsulated COPMA 15 ‐XG 3.5 hydrogel on day 1, day 7, and day 28 at ×500 magnification. The blue highlights indicate the presence of hMSCs. Scale bar: 20 µm. G,H) GAG/DNA and COL/DNA in hMSC encapsulated COPMA 15 ‐XG 3.5 hydrogels on day 1, 14, and 28 (n ≥ 3, **** p < 0.0001).

    Journal: Advanced Healthcare Materials

    Article Title: Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration

    doi: 10.1002/adhm.202502341

    Figure Lengend Snippet: Biocompatibility of hMSCs laden COPMA 15 ‐XG 3.5 constructs. A) Optical image of bioprinted hMSCs laden COPMA 15 ‐XG 3.5 hydrogel. B) Size statistics of bioprinted constructs. C) Metabolic activity. D‐E) Live/dead staining of hydrogels in proliferation medium, and in differentiation medium, scale bar: 500 µm. F) SEM of hMSC encapsulated COPMA 15 ‐XG 3.5 hydrogel on day 1, day 7, and day 28 at ×500 magnification. The blue highlights indicate the presence of hMSCs. Scale bar: 20 µm. G,H) GAG/DNA and COL/DNA in hMSC encapsulated COPMA 15 ‐XG 3.5 hydrogels on day 1, 14, and 28 (n ≥ 3, **** p < 0.0001).

    Article Snippet: Human bone marrow mesenchymal stem cells (hMSCs) from PromoCell (donor Caucasian woman, 30 years old) were cultured in T225 flasks at a density of 1000 cells cm −2 in proliferation medium.

    Techniques: Construct, Activity Assay, Staining

    Immunostaining of COL‐I expression in hMSCs laden COPMA 15 ‐XG 3.5 hydrogels. A) In proliferation medium. B) In ligament differentiation medium. C) 3D reconstruction on day 1, and day 28 of the cellular network in hydrogels in differentiation condition. Scale bar: 100 µm. D) Relative fluorescence COL‐I area (%) in the constructs on day 1 and 28 (n ≥ 3, ns indicates not siginificant, * p > 0.05, ** p < 0.01, **** p < 0.0001).

    Journal: Advanced Healthcare Materials

    Article Title: Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration

    doi: 10.1002/adhm.202502341

    Figure Lengend Snippet: Immunostaining of COL‐I expression in hMSCs laden COPMA 15 ‐XG 3.5 hydrogels. A) In proliferation medium. B) In ligament differentiation medium. C) 3D reconstruction on day 1, and day 28 of the cellular network in hydrogels in differentiation condition. Scale bar: 100 µm. D) Relative fluorescence COL‐I area (%) in the constructs on day 1 and 28 (n ≥ 3, ns indicates not siginificant, * p > 0.05, ** p < 0.01, **** p < 0.0001).

    Article Snippet: Human bone marrow mesenchymal stem cells (hMSCs) from PromoCell (donor Caucasian woman, 30 years old) were cultured in T225 flasks at a density of 1000 cells cm −2 in proliferation medium.

    Techniques: Immunostaining, Expressing, Fluorescence, Construct

    Immunostaining of SCX expression in hMSCs laden COPMA 15 ‐XG 3.5 hydrogels on day 28. A) In proliferation medium. B) In differentiation medium. Scale bar: 100 µm. C) 3D reconstruction of the cellular network in hydrogels in proliferation medium (top) and differentiation medium (bottom). D) Relative fluorescence SCX area (%) in the constructs on day 28 (n ≥ 3, * p < 0.05).

    Journal: Advanced Healthcare Materials

    Article Title: Mechanical Reinforced and Self‐healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide‐Xanthan Gum Constructs for Ligament Regeneration

    doi: 10.1002/adhm.202502341

    Figure Lengend Snippet: Immunostaining of SCX expression in hMSCs laden COPMA 15 ‐XG 3.5 hydrogels on day 28. A) In proliferation medium. B) In differentiation medium. Scale bar: 100 µm. C) 3D reconstruction of the cellular network in hydrogels in proliferation medium (top) and differentiation medium (bottom). D) Relative fluorescence SCX area (%) in the constructs on day 28 (n ≥ 3, * p < 0.05).

    Article Snippet: Human bone marrow mesenchymal stem cells (hMSCs) from PromoCell (donor Caucasian woman, 30 years old) were cultured in T225 flasks at a density of 1000 cells cm −2 in proliferation medium.

    Techniques: Immunostaining, Expressing, Fluorescence, Construct